This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Munno, I.
Right arrow Articles by Paulling, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Munno, I.
Right arrow Articles by Paulling, E.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, 07 1995, 503-505, Vol 2, No. 4
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Immunomodulatory effects of alpha interferon and thymostimulin in patients with neoplasias

I Munno, M Marinaro, A Gesario, B Cannuscio, Y Michel and E Paulling
Istituto di Microbiologia, University of Bari, Italy.

In this report, we have evaluated the immunological effects following administration of alpha interferon (IFN-alpha) in combination with thymostimulin (TP-1), as well as of IFN-alpha and TP-1 alone in patients with neoplasias who underwent surgery and were subsequently treated with conventional chemotherapy. Data suggest that the combination of IFN-alpha and TP-1 is the most effective in the up- regulation of some immune parameters such as the CD4(+)-CD8+ cell- dependent antibacterial activity. Since this immune function plays an important role in the host protection against different targets such as invading microorganisms and/or neoplastic cells, the administration of TP-1-IFN-alpha is advisable for patients with neoplasias under chemotherapy.